JP2007507480A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007507480A5 JP2007507480A5 JP2006530592A JP2006530592A JP2007507480A5 JP 2007507480 A5 JP2007507480 A5 JP 2007507480A5 JP 2006530592 A JP2006530592 A JP 2006530592A JP 2006530592 A JP2006530592 A JP 2006530592A JP 2007507480 A5 JP2007507480 A5 JP 2007507480A5
- Authority
- JP
- Japan
- Prior art keywords
- fibrinogen
- product
- platelet
- platelets
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0323378.0A GB0323378D0 (en) | 2003-10-07 | 2003-10-07 | Therapeutic agent |
| GB0323378.0 | 2003-10-07 | ||
| PCT/GB2004/004235 WO2005035002A1 (en) | 2003-10-07 | 2004-10-07 | Fibrinogen targetting microparticles for promoting haemostasie |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011143587A Division JP2011184465A (ja) | 2003-10-07 | 2011-06-28 | 止血を促進するためのフィブリノゲン標的微粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007507480A JP2007507480A (ja) | 2007-03-29 |
| JP2007507480A5 true JP2007507480A5 (enExample) | 2007-11-22 |
| JP4938454B2 JP4938454B2 (ja) | 2012-05-23 |
Family
ID=29415609
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006530592A Expired - Fee Related JP4938454B2 (ja) | 2003-10-07 | 2004-10-07 | 止血を促進するためのフィブリノゲン標的微粒子 |
| JP2011143587A Withdrawn JP2011184465A (ja) | 2003-10-07 | 2011-06-28 | 止血を促進するためのフィブリノゲン標的微粒子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011143587A Withdrawn JP2011184465A (ja) | 2003-10-07 | 2011-06-28 | 止血を促進するためのフィブリノゲン標的微粒子 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20080064628A1 (enExample) |
| EP (1) | EP1677829B1 (enExample) |
| JP (2) | JP4938454B2 (enExample) |
| CN (1) | CN1863560A (enExample) |
| AU (1) | AU2004280115B2 (enExample) |
| CA (1) | CA2541005C (enExample) |
| GB (1) | GB0323378D0 (enExample) |
| IL (1) | IL174580A0 (enExample) |
| WO (1) | WO2005035002A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0516091D0 (en) * | 2005-08-04 | 2005-09-14 | Haemostatix Ltd | Therapeutic agent |
| GB0623607D0 (en) | 2006-11-27 | 2007-01-03 | Haemostatix Ltd | Tissue adhesive |
| US9114127B2 (en) * | 2007-05-15 | 2015-08-25 | Richard C. K. Yen | Biologic devices for hemostasis |
| US20100204107A1 (en) * | 2007-09-11 | 2010-08-12 | Dorian Bevec | Use of urodilatin as a therapeutic agent |
| KR20100057061A (ko) * | 2007-09-11 | 2010-05-28 | 몬도바이오테크 래보래토리즈 아게 | 치료제로서의 펩티드 ｍａｉｐｐｋｋｎｑｄｋ （소 카파 카세인 １０６－１１６）및／또는 ｙｇｆｑｎａ （세로르핀）의 용도 |
| GB201101740D0 (en) * | 2011-02-01 | 2011-03-16 | Haemostatix Ltd | Therapeutic agents with improved fibrinogen binding |
| GB201201751D0 (en) * | 2012-02-01 | 2012-03-14 | Haemostatix Ltd | Haemostatic wound dressing |
| GB201204868D0 (en) | 2012-03-20 | 2012-05-02 | San Raffaele Centro Fond | Peptides |
| AU2013334180A1 (en) * | 2012-10-25 | 2015-05-14 | The Children's Hospital Of Philadelphia | Affinity peptide-modified particles and targeted drug delivery methods |
| GB201508024D0 (en) * | 2015-05-11 | 2015-06-24 | Haemostatix Ltd | Haemostatic compositions |
| WO2017103914A1 (en) * | 2015-12-17 | 2017-06-22 | Regentis Biomaterials Ltd. | Ready for use organic solvent free compositions comprising protein-polymer conjugates and uses thereof |
| EP3887404A4 (en) | 2018-11-30 | 2022-11-02 | Cellphire, Inc. | SLIDES LOADED WITH ANTI-CANCER AGENTS |
| US11767511B2 (en) | 2018-11-30 | 2023-09-26 | Cellphire, Inc. | Platelets as delivery agents |
| CA3138529C (en) | 2019-05-03 | 2025-10-07 | Cellphire, Inc. | MATERIALS AND PROCESSES FOR THE PRODUCTION OF BLOOD PRODUCTS |
| CN110448719B (zh) * | 2019-06-28 | 2020-05-22 | 浙江大学 | 一种促进凝血的丝素-多肽电纺膜及其制备方法 |
| WO2021034719A1 (en) | 2019-08-16 | 2021-02-25 | Cellphire, Inc. | Thrombosomes as an antiplatelet agent reversal agent |
| CA3170196A1 (en) | 2020-02-04 | 2021-08-12 | Cellphire, Inc. | Anti-fibrinolytic loaded platelets |
| TW202245814A (zh) | 2021-02-17 | 2022-12-01 | 美商賽菲爾公司 | 用於治療抗血小板誘導的凝血病之凍乾血小板衍生物組成物 |
| EP4416167A4 (en) * | 2021-10-15 | 2025-11-19 | Univ North Carolina State | COMPOSITIONS AND PROCESSES FOR PURIFYING BIOLOGICAL FLUIDS |
| US12702682B2 (en) | 2021-11-04 | 2026-08-11 | Cellphire, Inc. | Platelet derivative compositions, and methods of making and using such compositions |
| GB2642384A (en) * | 2023-01-31 | 2026-01-07 | Univ North Carolina State | Compositions and methods for purifying biological fluids |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5357042A (en) * | 1984-04-23 | 1994-10-18 | The General Hospital Corporation | Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity |
| US6391343B1 (en) * | 1991-01-15 | 2002-05-21 | Hemosphere, Inc. | Fibrinogen-coated particles for therapeutic use |
| DE4310632A1 (de) | 1993-04-01 | 1994-10-06 | Merck Patent Gmbh | Lineare Adhäsionsinhibitoren |
| DE69529917T2 (de) * | 1994-12-16 | 2003-12-11 | Elan Drug Delivery Ltd., Ruddington | Vernetzte mikropartikel und ihre verwendung als arzneiträger |
| AU718956B2 (en) * | 1996-10-21 | 2000-05-04 | Quadrant Healthcare (Uk) Limited | Platelet substitutes and conjugation methods suitable for their preparation |
| GB9724143D0 (en) | 1997-11-14 | 1998-01-14 | Andaris Ltd | Pharmaceutical conjugate |
| US20030021777A1 (en) * | 1998-02-20 | 2003-01-30 | Roy Harris | Product comprising bound fibrinogen and thrombin for use in wound therapy or surgical repair |
| US20040127416A1 (en) | 2002-11-15 | 2004-07-01 | Massia Stephen P. | Therapeutic bioconjugates |
-
2003
- 2003-10-07 GB GBGB0323378.0A patent/GB0323378D0/en not_active Ceased
-
2004
- 2004-10-07 CA CA2541005A patent/CA2541005C/en not_active Expired - Fee Related
- 2004-10-07 EP EP04768770.2A patent/EP1677829B1/en not_active Expired - Lifetime
- 2004-10-07 JP JP2006530592A patent/JP4938454B2/ja not_active Expired - Fee Related
- 2004-10-07 AU AU2004280115A patent/AU2004280115B2/en not_active Ceased
- 2004-10-07 US US10/574,872 patent/US20080064628A1/en not_active Abandoned
- 2004-10-07 WO PCT/GB2004/004235 patent/WO2005035002A1/en not_active Ceased
- 2004-10-07 CN CNA200480029425XA patent/CN1863560A/zh active Pending
-
2006
- 2006-03-27 IL IL174580A patent/IL174580A0/en unknown
-
2011
- 2011-06-28 JP JP2011143587A patent/JP2011184465A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011184465A (ja) | 止血を促進するためのフィブリノゲン標的微粒子 | |
| Satta et al. | Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. | |
| JP5204490B2 (ja) | 出血の制御及び出血性疾患の治療のための止血剤としての細胞由来微粒子 | |
| US20130029913A1 (en) | Artificial platelets | |
| HU214884B (hu) | Vérlemezke membrán mikrorészecskék, ezeket tartalmazó gyógyászati és diagnosztikai készítmények és eljárás a mikrórészecskék és a készítmények előállítására | |
| Ghiran et al. | Expression and function of C1q receptors and C1q binding proteins at the cell surface | |
| WO2008121721A2 (en) | Targeted delivery and expression of procoagulant hemostatic activity | |
| US20250073271A1 (en) | Methods of administering platelet derivative compositions to reduce bleeding in subjects refractory to platelet transfusion | |
| JP6636443B2 (ja) | 出血性症候群の場合における失血を制御する及び／又は血小板の代用にすることが可能であるコラーゲンに基づいた注射用製剤 | |
| Gordz et al. | Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease | |
| Sloand et al. | DDAVP corrects the platelet dysfunction produced by cardiopulmonary by-pass, hemodialysis, and prolonged storage: Re-expression of glycoprotein Ib on the platelet membrane | |
| Bauer et al. | Blood, plasma proteins, coagulation, fibrinolysis, and thrombocyte function | |
| JP2020508963A (ja) | Ｒｍｐ組成物および使用方法 |